These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 10539862)
1. Animal models of chlamydia and atherosclerosis. Muhlestein JB Am Heart J; 1999 Nov; 138(5 Pt 2):S514-5. PubMed ID: 10539862 [No Abstract] [Full Text] [Related]
2. Mouse models of Chlamydia pneumoniae infection and atherosclerosis. Campbell LA; Kuo Cc Am Heart J; 1999 Nov; 138(5 Pt 2):S516-8. PubMed ID: 10539863 [No Abstract] [Full Text] [Related]
3. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Muhlestein JB; Anderson JL; Hammond EH; Zhao L; Trehan S; Schwobe EP; Carlquist JF Circulation; 1998 Feb; 97(7):633-6. PubMed ID: 9495296 [TBL] [Abstract][Full Text] [Related]
8. Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae. Rothstein NM; Quinn TC; Madico G; Gaydos CA; Lowenstein CJ J Infect Dis; 2001 Jan; 183(2):232-238. PubMed ID: 11120929 [TBL] [Abstract][Full Text] [Related]
9. Antibiotics effects in a rabbit model of Chlamydia pneumoniae-induced atherosclerosis. Fong IW J Infect Dis; 2000 Jun; 181 Suppl 3():S514-8. PubMed ID: 10839750 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial therapy for Chlamydia pneumoniae: its potential role in atherosclerosis and asthma. Cook PJ J Antimicrob Chemother; 1999 Aug; 44(2):145-8. PubMed ID: 10473220 [No Abstract] [Full Text] [Related]
11. [Chlamydia pneumoniae and arteriosclerosis: an innocent onlooker?]. Vidal Verdú E An Med Interna; 1999 Jul; 16(7):329-32. PubMed ID: 10481330 [No Abstract] [Full Text] [Related]
12. [Chlamydia pneumoniae and atherosclerosis]. Marre R; Essig A Dtsch Med Wochenschr; 1997 Sep; 122(36):1092-5. PubMed ID: 9333534 [No Abstract] [Full Text] [Related]
13. Chlamydia pneumoniae and multiple infections in the aorta contribute to atherosclerosis. Shi Y; Tokunaga O Pathol Int; 2002 Dec; 52(12):755-63. PubMed ID: 12588444 [TBL] [Abstract][Full Text] [Related]
15. Mouse models of C. pneumoniae infection and atherosclerosis. Campbell LA; Blessing E; Rosenfeld M; Lin Tm; Kuo C J Infect Dis; 2000 Jun; 181 Suppl 3():S508-13. PubMed ID: 10839749 [TBL] [Abstract][Full Text] [Related]
16. How to design studies to confirm a link between bacterial infection and atherosclerosis. Campbell LA Am Heart J; 1999 Nov; 138(5 Pt 2):S552-3. PubMed ID: 10539873 [No Abstract] [Full Text] [Related]
17. [Chlamydia pneumoniae and atherosclerosis--the hen, the egg or five feathers?]. Møller K; Skinhøj P Ugeskr Laeger; 1999 Sep; 161(37):5173-4. PubMed ID: 10523951 [No Abstract] [Full Text] [Related]
18. Chlamydia pneumoniae, monocyte activation, and azithromycin in coronary heart disease. Gupta S Am Heart J; 1999 Nov; 138(5 Pt 2):S539-41. PubMed ID: 10539869 [No Abstract] [Full Text] [Related]
19. [Infection hypothesis for the pathogenesis of atherosclerosis--caused by Chlamydia pneumoniae?]. Durkalec J; Hasik J Przegl Lek; 1999; 56(4):299-301. PubMed ID: 10494168 [TBL] [Abstract][Full Text] [Related]
20. Chlamydia pneumonia (and other infective agents) in atherosclerosis and acute coronary syndromes. How good is the evidence? Camm AJ; Fox KM Eur Heart J; 2000 Jul; 21(13):1046-51. PubMed ID: 10843822 [No Abstract] [Full Text] [Related] [Next] [New Search]